Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in CashFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitShares OutstandingShares Outstanding
Ratios

Goldenwell Biotech (GWLL) Long-Term Debt Issuances (2023 - 2024)

Goldenwell Biotech filings provide 2 years of Long-Term Debt Issuances readings, the most recent being -$49250.0 for Q4 2024.

  • On a quarterly basis, Long-Term Debt Issuances fell 415.95% to -$49250.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $15588.0, a 79.38% decrease, with the full-year FY2023 number at $75588.0, up 277.94% from a year prior.
  • Long-Term Debt Issuances hit -$49250.0 in Q4 2024 for Goldenwell Biotech, down from $49250.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $49250.0 in Q2 2024 to a low of -$49250.0 in Q4 2024.